Korea Research Institute of Bioscience and Biotechnology;Enzychem Lifesciences Corporation
发明人:
Kim, Jae Wha,Oh, Sei Ryang,Ahn, Kyung Seop,Kang, Ho Bum,Park, Beom Su,Lee, Tae Suk,Kang, Jong Koo,Jung, Young Sik,Han, Yong-Hae,Sohn, Ki-Young
申请号：
AU2014309637
公开号：
AU2014309637A1
申请日:
2014.08.18
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
The present invention relates to a pharmaceutical composition for preventing, treating, or alleviating rheumatoid arthritis, a composition for a functional health food, and a medicinal compound. The monoacetyldiglyceride compound according to the present invention has excellent effects of inhibiting phosphorylation of STAT-3, which is known as a target material in treating rheumatoid arthritis, and thus can overcome side effects of currently used therapeutic agents for rheumatoid arthritis. Also, the monoacetyldiglyceride compound is a non-toxic compound having superior therapeutic effects and thus can be useful as a composition for preventing, treating, and alleviating rheumatoid arthritis.
